戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1         We conclude with some guidelines for guideline development.
2 oducibility of our findings and help support guideline development.
3 d patient outcomes to inform future pandemic guideline development.
4 0% probability of a refill by age to further guideline development.
5 o share their perspectives to further inform guideline development.
6  of clinical guidelines as the framework for guideline development.
7 nt care, and those establishing policies for guideline development.
8 , to validate the process and outcome of the guideline development.
9  No industry funding was associated with the guideline development.
10 nforced their Administrative Regulations for guideline development.
11  abiding commitment to methodologic rigor in guideline development.
12 ewed looking for evidence to inform practice guideline development.
13 e considered in clinical decision-making and guideline development.
14 the need to collect baseline data to support guideline development.
15 s used to evaluate rigor and transparency of guideline development.
16 ment on a set of international standards for guideline development.
17 s G-I-N's proposed set of key components for guideline development.
18 subgroups, served as an integral part of the guideline development.
19 RADE) working group as a unified approach to guideline development.
20 n modeling is warranted in future efforts at guideline development.
21 ), health professional education (145, 27%), guideline development (33, 6%), and formulary selection
22  of Medicine procedure for clinical practice guideline development, a PubMed, EMBASE, and Web of Scie
23                        Typically, methods of guideline development, a summary of the supporting evide
24                                     Clinical guideline development and clinical decisions about treat
25 PC charts were used to measure the effect of guideline development and distribution, a visiting lectu
26            Cure probabilities may facilitate guideline development and evaluating individual patients
27          However, physician participation in guideline development and evidence of poor compliance al
28                                         Both guideline development and final modifications were infor
29 SD) adherence to methodological standards on guideline development and format was 51.1% (25.3%); on i
30 n the planning of research, evidence review, guideline development and guideline implementation is mo
31              ASCO is implementing a range of guideline development and implementation innovations.
32      Stakeholder and public comment informed guideline development and modifications.
33                     These results can inform guideline development and patient-directed informed deci
34                                              Guideline development and performance improvement activi
35 March 2022 were also considered for practice guideline development and shared with collaborator group
36 ss the transition from systematic reviews to guideline development and the implications of CER in thi
37      This review discusses the rationale for guideline development and the role of clinical practice
38                              This may inform guideline development, and enhance shared decision-makin
39 shed evidence and the information needed for guideline development applying new or updated informatio
40  In contrast to other existing standards for guideline development at national or local levels, the k
41 for NMA are insufficient for the purposes of guideline development, because the influence of the evid
42 partments play a critical role in policy and guideline development both for the department and for th
43 al group technique are often used as part of guideline development, but little is known about factors
44  the IOM principles for trustworthy clinical guideline development by creating a single generalist gr
45                 Despite prevalent funding of guideline development by industry, such funding is not a
46                                              Guideline development by its nature is a process and met
47                                Standards for guideline development can help organizations ensure that
48                                          The guideline development committee included pediatric surge
49      An American Thoracic Society-sanctioned guideline development committee selected clinical questi
50 oaches are relatively similar throughout the guideline development community, with an increasing reco
51                          Rigorous methods of guideline development differentiate current guidelines f
52 ether a modified Delphi process early during guideline development discriminates recommendations that
53 hree people with expertise and experience in guideline development, dissemination, and implementation
54                        NCCN uses a system of guideline development distinct from other major professi
55 ce of S. mansoni Given the proper method and guideline development, eDNA could become an essential fu
56  Practice Work Group convened a joint VA/DoD guideline development effort that included a multidiscip
57 e Work Group (EBPWG) convened a joint VA/DoD guideline development effort that included clinical stak
58  Practice Work Group convened a joint VA/DoD guideline development effort that included clinical stak
59  Practice Work Group convened a joint VA/DoD guideline development effort that included clinical stak
60 Practice Work Group initiated a joint VA/DoD guideline development effort that included clinical stak
61 plinary team of 29 members with expertise in guideline development, evidence analysis, and family-cen
62 sing on their approaches to panel expertise, guideline development, evidence grading, and revision sc
63                     Many groups charged with guideline development find the lengthy list of standards
64                       These results may help guideline development for both the types and timing of c
65                               Evidence-based guideline development for surgical and dental prescribin
66    With a view to inform policy and national guidelines development for the Sustainable Development G
67 ties include research, healthcare education, guideline development, formulary selection, and clinical
68        Most organizations that are active in guideline development found the component items to be co
69 ough education and awareness, cost-conscious guideline development, government regulation, and market
70 sus was reached on 17 of 18 questions by the guideline development group and expert panel with high c
71 ible and cost-effective health strategy, the guideline development group made 13 specific recommendat
72  During a World Health Organization-convened Guideline Development Group meeting, recommendations for
73                          A multidisciplinary guideline development group posed review questions, disc
74                            The international guideline development group, Kidney Disease Improving Gl
75 rmed the World Health Organization technical guidelines development group in the development of the r
76  of women, included patient advocates in the guidelines development group, and focused on good commun
77 dies often do not provide evidence needed by guideline development groups to evaluate the tradeoffs b
78 d to offer harmonized recommendations across guideline development groups.
79 he Institute of Medicine (IOM) standards for guideline development have had unintended negative conse
80 This methods report describes the process of guideline development in detail.
81  were strictly followed during all phases of guideline development including task force selection and
82 d by adhering to international standards for guideline development, including adopting systematic rev
83 ct of interest policies in all phases of the guideline development, including task force selection an
84                                              Guideline development involved a systematic literature r
85                                              Guideline development involved a systematic literature r
86                                              Guideline development involved a systematic review of th
87                       Evidence-based feeding guideline development is crucial to improve outcomes in
88 d clinical need, research evidence to inform guideline development is necessary, and in the interim,
89                                       During guideline development, it is essential to systematically
90 ed in evidence-based medicine or involved in guideline development, journal editors, and manuscript r
91 pecific domains or focused solely on ethical guideline development-lacking a comprehensive framework
92 ctivities have primarily focused on clinical guideline development, little is known about the value p
93  evaluation, behavior modification, practice guideline development, medical informatics, and outcomes
94                              Since 2007, WHO guideline development methods have become more systemati
95                           While all areas of guideline development need improvement, greatest improve
96 id not undergo sustained improvement despite guideline development or distribution, a lecture by a vi
97 ws that are commissioned to support clinical guideline development or for other health policy uses.
98 pplied the WikiGuideline method for clinical guideline development, oral transitional therapy was at
99 ne and endorse guidelines developed by other guideline development organizations.
100 i-institutional task force with expertise in guideline development, pain, agitation and sedation, del
101                             An international guideline development panel including four people living
102                             An international guideline development panel including patients, clinicia
103                             An international guideline development panel including patients, clinicia
104                                          The guideline development panel made a strong recommendation
105                             An international guideline development panel of content experts, clinicia
106 elines, the standards for participation on a guideline development panel should be high.
107  for evaluation of qualitative research into guideline development procedures.
108 ature for each recommendation, following the guideline development process as outlined in the ASCO Gu
109           Anyone involved in any part of the guideline development process disclosed all commercial r
110                                          The guideline development process included (1) an overview o
111  additionally reflect on shortcomings in the guideline development process itself, which may have led
112 rts will serve as the basis for the ultimate guideline development process to be conducted by the Aca
113            The search was updated during the guideline development process to include published liter
114                                       In the guideline development process, a panel of experts formul
115 ccordance with the American Thoracic Society guideline development process, which is in compliance wi
116 ial part of patient-centered care and of the guideline development process.
117 delines for Research & Evaluation (AGREE II) guideline development process.
118 elated to sex and gender at the start of the guideline development process; assess the applicability,
119         The Cochrane Gut Group supported the guideline-development process, including conducting lite
120 d patterns developed during the 2010 Dietary Guidelines development process were used as the base for
121 icy was followed and enforced throughout the guidelines-development process.
122  interest policy was followed throughout the guidelines-development process.
123 pported by an evidence review and follow the guideline development processes outlined in the ASCO Gui
124                                       Future guideline development processes should consider methods
125 ard of trustees recognized the importance of guideline development processes that are both rigorous a
126                               The quality of guideline development processes varied substantially.
127                                              Guideline development processes vary substantially, and
128 literature review or adherence with clinical guideline development processes.
129 rm the international resuscitation councils' guideline development processes.
130 on based on the methodological framework for guideline development proposed by the Enhancing the Qual
131 nvolving patients and families as members of guideline development represent opportunities for future
132                                              Guideline development requires the synthesis of evidence
133 epresentatives of 22 organizations active in guideline development reviewed the proposed items and co
134 oach offers a novel methodology for clinical guideline development that precludes recommendations bas
135 s, or community standing." In the context of guideline development, the concerns are not simply about
136 f feedback from experts on clinical practice guideline development, the external validity and interra
137 plied the WikiGuidelines method for clinical guideline development, the majority of topics relating t
138 sought to identify gaps to inform future IEI guideline development, thereby supporting improved clini
139 bing, highlighting the need for further ADHD guideline development to define treatment appropriatenes
140 data to guide clinical practice and clinical guideline development to optimize laboratory monitoring
141  2 reviewers independently assessed rigor of guideline development using the Appraisal of Guidelines
142 ndations following standards for trustworthy guideline development using the Grading of Recommendatio
143 nd procedural legitimacy all play in ethical guideline development, we promote rigor and transparency
144 d Web sites of organizations responsible for guideline development were searched.
145               Quality assurance and practice guideline development were the most frequently reported
146 h the stance of the Institute of Medicine on guideline development, which is that high-quality eviden
147 will ultimately provide the underpinning for guideline development will be conducted by the Academy o
148                              The KDIGO Lipid Guideline Development Work Group defined the scope of th
149                                The KDIGO CKD Guideline Development Work Group defined the scope of th

 
Page Top